Lv1
40 积分 2025-06-09 加入
Survival analysis after liver resection for hepatocellular carcinoma: A consecutive cohort of 1002 patients
1个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
